Aptorum Group Limited Class A Ordinary Shares, also called Aptorum Group, is a pharmaceutical company dedicated to the discovery, development and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. It operates through the Therapeutics and Non-Therapeutics segments. Read More The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, metabolic disorders, women's health and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; operates the activities of AML Clinic; and sale of natural supplement. The firm’s pipe line is enriched through the establishment of drug discovery platforms that enable the discovery of new therapeutics assets. It also has projects focused on natural supplement for women undergoing menopause and experiencing related symptoms. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom. The listed name for APM is Aptorum Group Limited Class A Ordinary Shares.